Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo

Glucocorticoid-induced osteoporosis is a frequent complication of systemic glucocorticoid (GC) therapy and mainly characterized by suppressed osteoblast activity. Wnt16 derived from osteogenic cells is a key determinant of bone mass. Here, we assessed whether GC suppress bone formation via inhibitin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hildebrandt, Susanne, Baschant, Ulrike, Thiele, Sylvia, Tuckermann, Jan, Hofbauer, Lorenz C., Rauner, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992207/
https://www.ncbi.nlm.nih.gov/pubmed/29880826
http://dx.doi.org/10.1038/s41598-018-26300-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992207/
https://www.ncbi.nlm.nih.gov/pubmed/29880826
http://dx.doi.org/10.1038/s41598-018-26300-z

Ejemplares similares